New Product Planning Director, Cardiorenal
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Are you ready to make an impact by shaping the early-stage Research & Development pipeline and developing the portfolio analyses needed to inform decisions at senior management level? Would you like to apply your background in business and/ or science to assess business opportunities that will change the lives of millions living with Other Serious Chronic Diseases (OSCD)? Then you may be the candidate we are looking for as our new New Product Planning (NPP) Director for Cardiorenal. Join our expansion into new therapeutic areas. Apply now for a life-changing career!
About the department The OSCD Early Portfolio & Insights (EP&I) area sets the commercial direction for Novo Nordisk’s future drug portfolio within Other Serious Chronic Diseases: cardiovascular disease, kidney disease, Alzheimer’s disease, and Non-alcoholic Steatohepatitis (NASH)/liver disease. The EP&I area consists of departments covering NPP, Competitive Intelligence, Customer Insights, and Forecasting. Within EP&I, the NPP department has the commercial responsibility for the early portfolio of projects across the different therapeutic areas. You will join a team of six experienced NPP professionals like yourself and you will work in collaboration with the broader NPP team across all of Novo Nordisk’s strategic areas. Together with our good colleagues across Novo Nordisk, we are proud to be guiding the commercial success of the long-term future for Novo Nordisk. We are dedicated to delivering top-quality quantitative and qualitative commercial assessments on which to found critical portfolio decisions. While sharing a pursuit of ambitious goals we’re focused on maintaining a healthy and creative work culture and work-life balance.
The position
Your key tasks will be to ensure strong portfolio management of areas within cardiorenal and to drive commercial contributions to strategy execution such as ensuring that our commercial guidance to research is updated and implemented. You will drive development and collection of commercial input for early-stage projects and ensure strong alignment across broad commercial functions in headquarter and key affiliates. Furthermore, act as a sparring partner for the broader NPP team, and you will ensure strong onboarding and mentoring of new members of the NPP team. For key projects in the portfolio, you will work within the project team of a drug candidate to develop the target product profile, collecting primary and secondary data on market conditions, and shape the data into actionable recommendations. This is a great opportunity to make your impact on a truly global scale by: Being responsible for portfolio management, commercial guidance to research and commercial assessments of projects within the cardiorenal area Coordinating commercial input for the Product Development Plan and create financial valuations of assets as they prepare to enter Phase 2 clinical development Working with the broad NPP team to deliver the annual value assessment of the development portfolio Working on a variety of ad hoc commercial assessments that provide senior management with insights on long-term trends in our key markets. On a daily basis, you will work in a global context but interact primarily with headquarter function across a diverse network of internal colleagues from Research & Development, Commercial, Global Evidence & Patient Access, Strategic Finance, and Product Supply. You will report to the Vice President of OSCD Early Portfolio & Insights. You should expect up to 10 travel days per year.
Qualifications
As an ideal candidate, you have: Master’s degree in business or economics, or a scientific master’s degree with the addition of a business degree 10 years or more experience from working in commercial and/ or scientific functions within the pharmaceutical industry As part of this, extensive experience from working within New Product Planning, Business Development or similar functions Strong financial and analytical skills with a proven ability to translate analysis into insights and recommendations Excellent written and spoken English with strong communication skills It is an advantage to have previous experience working within: Cardiovascular disease, kidney disease, neurology and/or liver disease incl. NASH Brand teams Key functions within the drug development value chain On the personal side, we expect you to have excellent interpersonal skills, as this position requires you to work across multiple stakeholders in the company. You have a strong track record of delivering in high quality and finding new ways of achieving goals. You are pro-active and innovative and inspire ways of working smarter and taking team performance to a higher level and have demonstrated the ability to work individually as well as part of a team on multiple projects in parallel.
Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. That’s why we’re putting our almost a century's worth of industry experience into a new venture – Obesity Therapy. And we want you to be at the forefront of it all. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to move the needle on patient care.
Contact
Should you have questions about the position, please do not hesitate to contact Frank Daniel Mersebach at +45 3079 4807. Deadline 26 March 2023. We will review applications on an ongoing basis so we encourage you to apply as soon as possible. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
About the department The OSCD Early Portfolio & Insights (EP&I) area sets the commercial direction for Novo Nordisk’s future drug portfolio within Other Serious Chronic Diseases: cardiovascular disease, kidney disease, Alzheimer’s disease, and Non-alcoholic Steatohepatitis (NASH)/liver disease. The EP&I area consists of departments covering NPP, Competitive Intelligence, Customer Insights, and Forecasting. Within EP&I, the NPP department has the commercial responsibility for the early portfolio of projects across the different therapeutic areas. You will join a team of six experienced NPP professionals like yourself and you will work in collaboration with the broader NPP team across all of Novo Nordisk’s strategic areas. Together with our good colleagues across Novo Nordisk, we are proud to be guiding the commercial success of the long-term future for Novo Nordisk. We are dedicated to delivering top-quality quantitative and qualitative commercial assessments on which to found critical portfolio decisions. While sharing a pursuit of ambitious goals we’re focused on maintaining a healthy and creative work culture and work-life balance.
The position
Your key tasks will be to ensure strong portfolio management of areas within cardiorenal and to drive commercial contributions to strategy execution such as ensuring that our commercial guidance to research is updated and implemented. You will drive development and collection of commercial input for early-stage projects and ensure strong alignment across broad commercial functions in headquarter and key affiliates. Furthermore, act as a sparring partner for the broader NPP team, and you will ensure strong onboarding and mentoring of new members of the NPP team. For key projects in the portfolio, you will work within the project team of a drug candidate to develop the target product profile, collecting primary and secondary data on market conditions, and shape the data into actionable recommendations. This is a great opportunity to make your impact on a truly global scale by:
Qualifications
As an ideal candidate, you have:
Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. That’s why we’re putting our almost a century's worth of industry experience into a new venture – Obesity Therapy. And we want you to be at the forefront of it all. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to move the needle on patient care.
Contact
Should you have questions about the position, please do not hesitate to contact Frank Daniel Mersebach at +45 3079 4807. Deadline 26 March 2023. We will review applications on an ongoing basis so we encourage you to apply as soon as possible. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Marketingmedarbejder", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 3.3.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Marketingmedarbejder
- Søborg
Lignende jobs
-
Marketingmedarbejder i Glostrup
Få mere info- Marketingmedarbejder
- Glostrup
-
Marketingmedarbejder (studiejob) i København
Hvem er [xxxxx]?[xxxxx] skaber udviklingsmuligheder i samspillet mellem studerende og virksomheder. Vi gør det let for erhvervslivet at opnå resultater med ansættelser af studerende - og det er her, .Få mere info- Marketingmedarbejder
- København
-
Marketingmedarbejder i Ballerup
Få mere info- Marketingmedarbejder
- Ballerup
-
Marketingmedarbejder i Kastrup
WE ARE LOOKING FOR SAS CARGO’S NEW CARGO AIR FREIGHT BUSINESS PRODUCT MANAGERSAS Cargo has been successful in capturing the growth in the market and is an enabler for the profitability of SAS l..Få mere info- Marketingmedarbejder
- Kastrup
Statistik over udbudte jobs som marketingmedarbejdere i Søborg
Herunder ser du udviklingen i udbudte marketingmedarbejder i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal marketingmedarbejdere.
Se flere statistikker her:
Statistik over udbudte marketingmedarbejdere over tid
| Dato | Alle jobs som marketingmedarbejdere |
|---|---|
| 23. april 2024 | 1 |
| 22. april 2024 | 1 |
| 21. april 2024 | 1 |
| 20. april 2024 | 1 |
| 19. april 2024 | 1 |
| 18. april 2024 | 1 |
| 17. april 2024 | 2 |
| 16. april 2024 | 2 |
| 15. april 2024 | 2 |
| 14. april 2024 | 2 |
| 13. april 2024 | 2 |
| 12. april 2024 | 2 |
| 11. april 2024 | 2 |
| 10. april 2024 | 2 |
| 9. april 2024 | 2 |
| 8. april 2024 | 2 |
| 7. april 2024 | 3 |
| 6. april 2024 | 3 |
| 5. april 2024 | 3 |
| 4. april 2024 | 2 |
| 3. april 2024 | 2 |
| 2. april 2024 | 2 |
| 1. april 2024 | 3 |
| 31. marts 2024 | 5 |
| 30. marts 2024 | 5 |
| 29. marts 2024 | 5 |
| 28. marts 2024 | 5 |
| 27. marts 2024 | 5 |
| 26. marts 2024 | 5 |
| 25. marts 2024 | 5 |
| 24. marts 2024 | 5 |